What does this research mean for the field?

In hospitalized patients receiving QT-prolonging medications, continuous ECG monitoring for premonitory signs such as marked QTc prolongation exceeding 500 ms and post-pause T-U wave distortion enables the early prevention and management of drug-induced torsade de pointes. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the mechanisms, risk factors, electrocardiographic harbingers, and clinical management strategies for preventing drug-induced long-QT syndrome and torsade de pointes in hospital settings.

July 18, 2026CirculationOpen Access

Prevention of Torsade de Pointes in Hospital Settings

View Full Paper

Ask AI

Bookmark

To review the mechanisms, risk factors, electrocardiographic harbingers, and clinical management strategies for preventing drug-induced long-QT syndrome and torsade de pointes in hospital settings.
Reviewed cellular mechanisms, genetic susceptibility, and electrophysiological properties of drug-induced torsade de pointes and long-QT syndrome.
Synthesized clinical cohort evidence and experimental models evaluating QT-interval prolongation, electrocardiographic distortion, and patient risk factors.
Each 10-ms increase in corrected QT interval (QTc) is associated with an exponential 5% to 7% increase in torsade de pointes risk, with a QTc >500 ms conferring a 2- to 3-fold higher risk.
Most offending medications block the rapid delayed rectifier potassium current (IKr), thereby prolonging myocardial action potential duration and enhancing transmural dispersion of repolarization.
Premonitory signs of impending arrhythmia include marked QTc prolongation exceeding 500 ms, short-long-short R-R interval sequences, T-U wave distortion, and macroscopic T-wave alternans.

Design

Guideline

Key expert perspectives

Captured external expert commentary on this paper, strongest first. Original sources are linked where available.

BJ Barbara J. DrewProfessor of nursing and cardiology, UC San Francisco

“This scientific statement is particularly important for healthcare professionals who administer QT-prolonging drugs in hospital units where patients have continuous ECG monitoring such as in ICUs. If the ECG warning signs of TdP are recognized on the patient's cardiac monitor, then TdP and subsequent cardiac arrest should be avoidable.”

University of California, San FranciscoNews Coverage

Implication

This scientific statement provides expert recommendations on ECG monitoring, risk assessment, and management strategies to prevent drug-induced torsade de pointes in hospital settings.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Drew et al. (2010) studied this question.

synapsesocial.com/papers/6a5bedce5b7c1ea55c781d87 https://doi.org/10.1161/circulationaha.109.192704

View Full Paper

Ask AI

Bookmark

Implication

This scientific statement provides expert recommendations on ECG monitoring, risk assessment, and management strategies to prevent drug-induced torsade de pointes in hospital settings.

Prevention of Torsade de Pointes in Hospital Settings

Key Points

Key expert perspectives

Implication

Discussion

Cite This Study

Prevention of Torsade de Pointes in Hospital Settings

Key Points

Key expert perspectives

Implication

Discussion

Cite This Study

Keep reading

Keep reading